Implications of micro-RNA profiling for cancer diagnosis

Oncogene

Volumn 25, Issue 46, 2006, Pages 6220-6227

  Cummins, J M ^a   Velculescu, V E ^a  

^a JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

Biomarkers; Cancer; Expression profiling; MicroRNAs; miRAGE; Molecular diagnostics

Indexed keywords

BIOLOGICAL MARKER; MICRORNA;

ACUTE LYMPHOCYTIC LEUKEMIA; B CELL LYMPHOMA; BREAST CANCER; CANCER; CARCINOGENESIS; CHRONIC LYMPHATIC LEUKEMIA; COLORECTAL CANCER; GENE CONTROL; GENE EXPRESSION PROFILING; HIGH THROUGHPUT SCREENING; HUMAN; LARGE CELL LYMPHOMA; LUNG CARCINOMA; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; REVIEW; RNA ANALYSIS; SERIAL ANALYSIS OF GENE EXPRESSION; THYROID PAPILLARY CARCINOMA;

GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MICRORNAS; NEOPLASMS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS;

CAENORHABDITIS ELEGANS; EUKARYOTA;

EID: 33749519036     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/sj.onc.1209914     Document Type: Review

References (86)

1. Ambros V. (2004). The functions of animal microRNAs. Nature 431: 350-355.
2. Ambros V, Horvitz HR. (1984). Heterochronic mutants of the nematode Caenorhabditis elegans. Science 226: 409-416.
3. Babak T, Zhang W, Morris Q, Blencowe BJ, Hughes TR. (2004). Probing microRNAs with microarrays: tissue specificity and functional inference. RNA 10: 1813-1819.
4. Barad O, Meiri E, Avniel A, Aharonov R, Barzilai A, Bentwich I et al. (2004). MicroRNA expression detected by oligonucleotide microarrays: system establishment and expression profiling in human tissues. Genome Res 14: 2486-2494.
5. Bartel DP. (2004). MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116: 281-297.
6. Bentwich I, Avniel A, Karov Y, Aharonov R, Gilad S, Barad O et al. (2005). Identification of hundreds of conserved and nonconserved human microRNAs. Nat Genet 37: 766-770.
7. Bernstein E, Kim SY, Carmell MA, Murchison EP, Alcorn H, Li MZ et al. (2003). Dicer is essential for mouse development. Nat Genet 35: 215-217.
8. Bottoni A, Piccin D, Tagliati F, Luchin A, Zatelli MC, degli Uberti EC. (2005). miR-15a and miR-16-1 down-regulation in pituitary adenomas. J Cell Physiol 204: 280-285.
9. Brennecke J, Hipfner DR, Stark A, Russell RB, Cohen SM. (2003). bantam encodes a developmentally regulated micro-RNA that controls cell proliferation and regulates the proapoptotic gene hid in Drosophila. Cell 113: 25-36.
10. Brigden ML, Murray N. (1999). Improving survival in metastatic carcinoma of unknown origin. Postgrad Med 105: 63-64, 67-74.
11. Caldas C, Brenton JD. (2005). Sizing up miRNAs as cancer genes. Nat Med 11: 712-714.
12. Calin GA, Croce CM. (2006). Genomics of chronic lymphocytic leukemia microRNAs as new players with clinical significance. Semin Oncol 33: 167-173.
13. Calin GA, Dumitru CD, Shimizu M, Bichi R, Zupo S, Noch E et al. (2002). Frequent deletions and down-regulation of micro-RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia. Proc Natl Acad Sci USA 99: 15524-15529.
14. Calin GA, Ferracin M, Cimmino A, Di Leva G, Shimizu M, Wojcik SE et al. (2005). A microRNA signature associated with prognosis and progression in chronic lymphocytic leukemia. N Engl J Med 353: 1793-1801.
15. Calin GA, Liu CG, Sevignani C, Ferracin M, Felli N, Dumitru CD et al. (2004a). MicroRNA profiling reveals distinct signatures in B cell chronic lymphocytic leukemias. Proc Natl Acad Sci USA 101: 11755-11760.
16. Calin GA, Sevignani C, Dumitru CD, Hyslop T, Noch E, Yendamuri S et al. (2004b). Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers. Proc Natl Acad Sci USA 101: 2999-3004.
17. Chan JA, Krichevsky AM, Kosik KS. (2005). MicroRNA-21 is an antiapoptotic factor in human glioblastoma cells. Cancer Res 65: 6029-6033.
18. Chen C, Ridzon DA, Broomer AJ, Zhou Z, Lee DH, Nguyen JT et al. (2005). Real-time quantification of microRNAs by stem-loop RT-PCR. Nucleic Acids Res 33: e179.
19. Chen CZ. (2005). MicroRNAs as oncogenes and tumor suppressors. N Engl J Med 353: 1768-1771.
20. Ciafre SA, Galardi S, Mangiola A, Ferracin M, Liu CG, Sabatino G et al. (2005). Extensive modulation of a set of microRNAs in primary glioblastoma. Biochem Biophys Res Commun 334: 1351-1358.
21. Cimmino A, Calin GA, Fabbri M, Iorio MV, Ferracin M, Shimizu M et al. (2005). miR-15 and miR-16 induce apoptosis by targeting BCL2. Proc Natl Acad Sci USA 102: 13944-13949.
22. Croce CM, Calin GA. (2005). miRNAs, cancer, and stem cell division. Cell 122: 6-7.
23. Cummins JM, He Y, Leary RJ, Pagliarini R, Diaz Jr LA, Sjoblom T et al. (2006). The colorectal microRNAome. Proc Natl Acad Sci USA 103: 3687-3692.
24. Eis PS, Tam W, Sun L, Chadburn A, Li Z, Gomez MF et al. (2005). Accumulation of miR-155 and BIC RNA in human B cell lymphomas. Proc Natl Acad Sci USA 102: 3627-3632.
25. Esau C, Kang X, Peralta E, Hanson E, Marcusson EG, Ravichandran LV et al. (2004). MicroRNA-143 regulates adipocyte differentiation. J Biol Chem 279: 52361-52365.
26. Esquela-Kerscher A, Slack FJ. (2006). Oncomirs - microRNAs with a role in cancer. Nat Rev Cancer 6: 259-269.
27. Gregory RI, Shiekhattar R. (2005). MicroRNA biogenesis and cancer. Cancer Res 65: 3509-3512.
28. Hall PA, Russell SH. (2005). New perspectives on neoplasia and the RNA world. Hematol Oncol 23: 49-53.
29. Hammond SM. (2006). MicroRNAs as oncogenes. Curr Opin Genet Dev 16: 4-9.
30. Hayashita Y, Osada H, Tatematsu Y, Yamada H, Yanagisawa K, Tomida S et al. (2005). A polycistronic microRNA cluster, miR-17-92, is overexpressed in human lung cancers and enhances cell proliferation. Cancer Res 65: 9628-9632.
31. He H, Jazdzewski K, Li W, Liyanarachchi S, Nagy R, Volinia S et al. (2005a). The role of microRNA genes in papillary thyroid carcinoma. Proc Natl Acad Sci USA 102: 19075-19080.
32. He L, Thomson JM, Hemann MT, Hernando-Monge E, Mu D, Goodson S et al. (2005b). A microRNA polycistron as a potential human oncogene. Nature 435: 828-833.
33. Hutvagner G, Simard MJ, Mello CC, Zamore PD. (2004). Sequence-specific inhibition of small RNA function. PLoS Biol 2: E98.
34. Hwang HW, Mendell JT. (2006). MicroRNAs in cell proliferation, cell death, and tumorigenesis. Br J Cancer 94: 776-780.
35. Iorio MV, Ferracin M, Liu CG, Veronese A, Spizzo R, Sabbioni S et al. (2005). MicroRNA gene expression deregulation in human breast cancer. Cancer Res 65: 7065-7070.
36. Johnson SM, Grosshans H, Shingara J, Byrom M, Jarvis R, Cheng A et al. (2005). RAS is regulated by the let-7 microRNA family. Cell 120: 635-647.
37. Kanellopoulou C, Muljo SA, Kung AL, Ganesan S, Drapkin R, Jenuwein T et al. (2005). Dicer-deficient mouse embryonic stem cells are defective in differentiation and centromeric silencing. Genes Dev 19: 489-501.
38. Kasashima K, Nakamura Y, Kozu T. (2004). Altered expression profiles of microRNAs during TPA-induced differentiation of HL-60 cells. Biochem Biophys Res Commun 322: 403-410.
39. Kloosterman WP, Wienholds E, de Bruijn E, Kauppinen S, Plasterk RH. (2006). In situ detection of miRNAs in animal embryos using LNA-modified oligonucleotide probes. Nat Methods 3: 27-29.
40. Kluiver J, Poppema S, de Jong D, Blokzijl T, Harms G, Jacobs S et al. (2005). BIC and miR-155 are highly expressed in Hodgkin, primary mediastinal and diffuse large B cell lymphomas. J Pathol 207: 243-249.
41. Kohli M, Rago C, Lengauer C, Kinzler KW, Vogelstein B. (2004). Facile methods for generating human somatic cell gene knockouts using recombinant adeno-associated viruses. Nucleic Acids Res 32: e3.
42. Lagos-Quintana M, Rauhut R, Lendeckel W, Tuschl T. (2001). Identification of novel genes coding for small expressed RNAs. Science 294: 853-858.
43. Lagos-Quintana M, Rauhut R, Meyer J, Borkhardt A, Tuschl T. (2003). New microRNAs from mouse and human. RNA 9: 175-179.
44. Lau NC, Lim LP, Weinstein EG, Bartel DP. (2001). An abundant class of tiny RNAs with probable regulatory roles in Caenorhabditis elegans. Science 294: 858-862.
45. Lee RC, Ambros V. (2001). An extensive class of small RNAs in Caenorhabditis elegans. Science 294: 862-864.
46. Lee RC, Feinbaum RL, Ambros V. (1993). The C. elegans heterochronic gene lin-4encodes small RNAs with antisense complementarity to lin-14. Cell 75: 843-854.
47. Lee YS, Kim HK, Chung S, Kim KS, Dutta A. (2005). Depletion of human micro-RNA miR-125b reveals that it is critical for the proliferation of differentiated cells but not for the down-regulation of putative targets during differentiation. J Biol Chem 280: 16635-16641.
48. Lewis BP, Burge CB, Bartel DP. (2005). Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell 120: 15-20.
49. Liang RQ, Li W, Li Y, Tan CY, Li JX, Jin YX et al. (2005). An oligonucleotide microarray for microRNA expression analysis based on labeling RNA with quantum dot and nanogold probe. Nucleic Acids Res 33: e17.
50. Lim LP, Glasner ME, Yekta S, Burge CB, Bartel DP. (2003). Vertebrate microRNA genes. Science 299: 1540.
51. Liu CG, Calin GA, Meloon B, Gamliel N, Sevignani C, Ferracin M et al. (2004). An oligonucleotide microchip for genome-wide microRNA profiling in human and mouse tissues. Proc Natl Acad Sci USA 101: 9740-9744.
52. Lu J, Getz G, Miska EA, Alvarez-Saavedra E, Lamb J, Peck D et al. (2005). MicroRNA expression profiles classify human cancers. Nature 435: 834-838.
53. McManus MT. (2003). MicroRNAs and cancer. Semin Cancer Biol 13: 253-258.
54. Meister G, Landthaler M, Dorsett Y, Tuschl T. (2004). Sequence-specific inhibition of microRNA- and siRNA-induced RNA silencing. RNA 10: 544-550.
55. Meltzer PS. (2005). Cancer genomics: small RNAs with big impacts. Nature 435: 745-746.
56. Mendell JT. (2005). MicroRNAs: critical regulators of development, cellular physiology and malignancy. Cell Cycle 4: 1179-1184.
57. Metzler M, Wilda M, Busch K, Viehmann S, Borkhardt A. (2004). High expression of precursor microRNA-155/BIC RNA in children with Burkitt lymphoma. Genes Chromosomes Cancer 39: 167-169.
58. Michael MZ, SM OC, van Holst Pellekaan NG, Young GP, James RJ. (2003). Reduced accumulation of specific microRNAs in colorectal neoplasia. Mol Cancer Res 1: 882-891.
59. Miska EA. (2005). How microRNAs control cell division, differentiation and death. Curr Opin Genet Dev 15: 563-568.
60. Morris JPt, McManus MT. (2005). Slowing down the Ras lane: miRNAs as tumor suppressors? Sci STKE 2005: pe41.
61. Muljo SA, Ansel KM, Kanellopoulou C, Livingston DM, Rao A, Rajewsky K. (2005). Aberrant T cell differentiation in the absence of Dicer. J Exp Med 202: 261-269.
62. Murchison EP, Partridge JF, Tam OH, Cheloufi S, Hannon GJ. (2005). Characterization of Dicer-deficient murine embryonic stem cells. Proc Natl Acad Sci USA 102: 12135-12140.
63. Neely LA, Patel S, Garver J, Gallo M, Hackett M, McLaughlin S et al. (2006). A single-molecule method for the quantitation of microRNA gene expression. Nat Methods 3: 41-46.
64. Nelson PT, Baldwin DA, Scearce LM, Oberholtzer JC, Tobias JW, Mourelatos Z. (2004). Microarray-based, high-throughput gene expression profiling of microRNAs. Nat Methods 1: 155-161.
65. O'Donnell KA, Wentzel EA, Zeller KI, Dang CV, Mendell JT. (2005). c-Myc-regulated microRNAs modulate E2F1 expression. Nature 435: 839-843.
66. Pallante P, Visone R, Ferracin M, Ferraro A, Berlingieri MT, Troncone G et al. (2006). MicroRNA deregulation in human thyroid papillary carcinomas. Endocr Relat Cancer 13: 497-508.
67. Pao W, Miller VA. (2005). Epidermal growth factor receptor mutations, small-molecule kinase inhibitors, and non-small-cell lung cancer: current knowledge and future directions. J Clin Oncol 23: 2556-2568.
68. Piccart-Gebhart MJ, Procter M, Leyland-Jones B, Goldhirsch A, Untch M, Smith I et al. (2005). Trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer. N Engl J Med 353: 1659-1672.
69. Ramaswamy S, Tamayo P, Rifkin R, Mukherjee S, Yeang CH, Angelo M et al. (2001). Multiclass cancer diagnosis using tumor gene expression signatures. Proc Natl Acad Sci USA 98: 15149-15154.
70. Raymond CK, Roberts BS, Garrett-Engele P, Lim LP, Johnson JM. (2005). Simple, quantitative primer-extension PCR assay for direct monitoring of microRNAs and short-interfering RNAs. RNA 11: 1737-1744.
71. Reinhart BJ, Slack FJ, Basson M, Pasquinelli AE, Bettinger JC, Rougvie AE et al. (2000). The 21-nucleotide let-7 RNA regulates developmental timing in Caenorhabditis elegans. Nature 403: 901-906.
72. Romond EH, Perez EA, Bryant J, Suman VJ, Geyer Jr CE, Davidson NE et al. (2005). Trastuzumab plus adjuvant chemotherapy for operable HER2-positive breast cancer. N Engl J Med 353: 1673-1684.
73. Schmittgen TD, Jiang J, Liu Q, Yang L. (2004). A high-throughput method to monitor the expression of microRNA precursors. Nucleic Acids Res 32: e43.
74. Service RF. (2006). Gene sequencing. The race for the $1000 genome. Science 311: 1544-1546.
75. Shi R, Chiang VL. (2005). Facile means for quantifying microRNA expression by real-time PCR. Biotechniques 39: 519-525.
76. Shingara J, Keiger K, Shelton J, Laosinchai-Wolf W, Powers P, Conrad R et al. (2005). An optimized isolation and labeling platform for accurate microRNA expression profiling. RNA 11: 1461-1470.
77. Slack FJ, Weidhaas JB. (2006). MicroRNAs as a potential magic bullet in cancer. Future Oncol 2: 73-82.
78. Stegmaier K, Ross KN, Colavito SA, O'Malley S, Stockwell BR, Golub TR. (2004). Gene expression-based high-throughput screening (GE-HTS) and application to leukemia differentiation. Nat Genet 36: 257-263.
79. Suh MR, Lee Y, Kim JY, Kim SK, Moon SH, Lee JY et al. (2004). Human embryonic stem cells express a unique set of microRNAs. Dev Biol 270: 488-498.
80. Takamizawa J, Konishi H, Yanagisawa K, Tomida S, Osada H, Endoh H et al. (2004). Reduced expression of the let-7 microRNAs in human lung cancers in association with shortened postoperative survival. Cancer Res 64: 3753-3756.
81. Thomson JM, Parker J, Perou CM, Hammond SM. (2004). A custom microarray platform for analysis of microRNA gene expression. Nat Methods 1: 47-53.
82. Varmus H, Pao W, Politi K, Podsypanina K, Du YC. (2005). Oncogenes come of age. Cold Spring Harb Symp Quant Biol 70: 1-9.
83. Volinia S, Calin GA, Liu CG, Ambs S, Cimmino A, Petrocca F et al. (2006). A microRNA expression signature of human solid tumors defines cancer gene targets. Proc Natl Acad Sci USA 103: 2257-2261.
84. Weinstein IB. (2002). Cancer. Addiction to oncogenes - the Achilles heal of cancer. Science 297: 63-64.
85. Xu P, Guo M, Hay BA. (2004). MicroRNAs and the regulation of cell death. Trends Genet 20: 617-624.
86. Yanaihara N, Caplen N, Bowman E, Seike M, Kumamoto K, Yi M et al. (2006). Unique microRNA molecular profiles in lung cancer diagnosis and prognosis. Cancer Cell 9: 189-198.